Pro-inflammatory cellular immune response in Behçet's disease

Rheumatology International

Volumn 27, Issue 12, 2007, Pages 1113-1118

  Kulaber, Ayla ^a   Tugal Tutkun, Ilknur ^a   Yentür, Sibel P ^a   Akman Demir, Gülşen ^a   Kaneko, Fumio ^b   Gül, Ahmet ^a   Saruhan Direskeneli, Güher ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

B Crystallin; Behcet's disease; BES 1 peptides; Cellular response

Indexed keywords

BACTERIAL PROTEIN; CRYSTALLIN; GAMMA INTERFERON; INTERLEUKIN 12; ISOPENTENYL DIPHOSPHATE; PROTEIN ALPHAB CRYSTALLIN; PROTEIN BES 1; PROTEIN KTH 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHCET DISEASE; CELL ACTIVITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STREPTOCOCCUS SANGUINIS; T LYMPHOCYTE; UPREGULATION;

ADULT; ALPHA-CRYSTALLIN B CHAIN; ANTIGENS, BACTERIAL; AZATHIOPRINE; BEHCET SYNDROME; CELL PROLIFERATION; CELLS, CULTURED; COLCHICINE; FEMALE; GLUCOCORTICOIDS; HEMITERPENES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; ORGANOPHOSPHORUS COMPOUNDS; UVEITIS;

EID: 34548514197     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0367-9     Document Type: Article

References (25)

1. Gul A (2001) Behcet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19:S6-S12
2. Direskeneli H (2001) Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996-1002
3. Yamamoto J, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet's disease. Br J Ophthalmol 77:584-589
4. Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, Nussenblatt RB (2005) Alpha tropomyosin as a self-antigen in patients with Behcet's disease. Clin Exp Immunol 140:368-375
5. Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol 21:S44-S48
6. Tasci B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock protein (hsp) 65 in the cerebrospinal fluid of neuro-Behcet patients. Clin Exp Immunol 113:100-104
7. Bhat S, Nagineni C (1989) Alpha B subunit of lens-specific protein α-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun 158:319-325
8. van Noort J, van Sechel A, Bajramovic J, el Ouagmiri M, Polman C, Lassmann H, Ravid R (1995) The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798-801
9. Celet B, Akman-Demir G, Serdaroglu P, Yentur SP, Tasci B, van Noort JM, Eraksoy M, Saruhan-Direskeneli G (2000) Anti-αB-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935-939
10. Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int Rev Immunol 14:21-32
11. Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fuji N (1998) Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet's disease. Zentralbl Bakteriol 287:449-460
12. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y (1992) Increased peripheral blood γδ + T cells and natural killer cells in Behcet's disease. J Rheumatol 19:588-592
13. Fortune F, Walker J, Lehner T (1990) The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet's syndrome. Clin Exp Immunol 82:326-332
14. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of γδ T lymphocytes in the development of Behcet's disease. Clin Exp Immunol 107:241-247
15. Bank I, Duvdevani M, Livneh A (2003) Expansion of γδ T-cells in Behcet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med, The (LAB) 141:33-40
16. Mochizuki N, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, Yamashita N, Hirayama K, Nakajima T, Mizushima Y (1994) Fine antigen specificity of human γδ T cell lines established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Str Sanguis. Eur J Immunol 24:1536-1543
17. Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J (2001) Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human γδ T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem 276:15961-15967
18. Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS (2002) Vγ9Vδ2 T cells recovered from eyes of patients with Behcet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 130:46-54
19. International Study Group for Behçet's, Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
20. Moss W, Ryon J, Monze M, Cutts F, Quinn T, Griffin D. (2002) Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 185:1035-1042
21. van Sechel AC, van Stipdonk MJB, Persoon-Deen C, Geutskens SB, van Noort JM (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of αB-crystallin, a candidate autoantigen in multiple slerosis. J Immunol 162:129-135
22. Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444-454
23. Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-γ by T cells from patients with Behcet's disease. Cell Immunol 140:410-419
24. Nishida T, Hirayama K, Nakamura S, Ohno S (1998) Proliferative response of CD8+ γδ + T cells to Streptococcus sanguis in patients with Behcet's disease. Ocul Immunol Inflamm 6:139-144
25. de Smet M, Dayan M (2000) Prospective determination of T-cell responses to S-antigen in Behcet's disease patients and controls. Invest Ophthalmol Vis Sci 41:3480-3484